Arrowhead Pharmaceuticals, Inc.
ARWR
Revenue
0.00
0.000.00%
3 Months ChangeAssets
883.76M
▼-71.39M▼-7.47%
3 Months ChangeLiabilities
553.21M
▲81.86M▲17.37%
3 Months ChangeFree Cash Flow
-186.50M
▼-72.07M▼-62.98%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 8-K
ID: 0001628280-24-036113
2024-08-08
Form 10-Q
ID: 0001628280-24-036104
2024-05-09
Form 8-K
ID: 0001628280-24-022233
2024-05-09
Form 10-Q
ID: 0001628280-24-022215
2024-03-19
Form 8-K
ID: 0001628280-24-011930
2024-02-22
Form 8-K
ID: 0001628280-24-005998
2024-02-06
Form 10-Q
ID: 0001628280-24-003492
2024-02-06
Form 8-K
ID: 0001628280-24-003488
2024-01-22
Form 8-K
ID: 0001628280-24-001805
2024-01-04
Form 8-K
ID: 0001628280-24-000480